Joanna Kedra, MD, MSc

IPLESP
Paris, France

Dr Joanna Kedra completed her medical education at Sorbonne Université (Paris, France) and did her Rheumatology residency in Assistance Publique – Hôpitaux de Paris (Paris, France). She also completed a Master 2 degree in clinical research and biostatistics in 2019 and is starting in November 2020 a PhD in pharmacoepidemiology.
Dr Kedra’s clinical interests focus on inflammatory joint diseases and systemic autoimmune disorders, especially rheumatoid arthritis treatments and outcomes.

Disclosure information not submitted.

Presentation(s):

• 1424: Cost-Effectiveness of a Progressive Spacing of Tocilizumab or Abatacept in Patients with Rheumatoid Arthritis in Sustained Remission: A Medico-Economic Analysis of the ToLEDo Trial

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time